Tissue Diagnostics Market Global Industry Analyses 2016-2020 an opportunity forecasted 2020-2030
Market Overview Tissue diagnostics is analyzing and evaluating particular tissue samples in order to understand the biological background of illnesses. They are used to detect specific medical pro... もっと見る
SummaryMarket OverviewTissue diagnostics is analyzing and evaluating particular tissue samples in order to understand the biological background of illnesses. They are used to detect specific medical problems including as cancer and inflammatory illnesses, as well as indicate the precise kind and degree of malignancy, which aids in the identification of probable causes and treatment choices. Tissue diagnostics are very accurate, low-cost, and may be done using a variety of procedures, including core and open biopsy. These diagnoses are now performed using modern technologies such as immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology, and special labelling. The disease insights and factors that influence patient outcomes are captured by tissue diagnostics. Tissues, in general, provide for individualized diagnosis and therapy. The majority of samples are made up of tissue fragments collected through various procedures. Small biopsies and huge specimens extracted during surgery are examples. Other important factors driving the market's growth are rising healthcare expenditures and technical developments in tissue diagnostics. Tissue Diagnostics Market: Key Players Abbott Laboratories Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis Agilent Technologies Inc. BioGenex Laboratories Cancer Genetics Inc. Danaher Corporation F. Hoffmann-La Roche Ltd Genomic Health Inc. Merck KGaA Thermo Fisher Scientific. Bio Rad Biomeriux Growth Factor Increased cancer patients The number of persons diagnosed with cancer has increased as a result of changing lifestyles, increased cigarette and alcohol intake, and rising incidence of lifestyle problems. The need for tissue diagnostics in the treatment of breast cancer, prostate cancer, and other cancers is propelling the market during the forecast period, owing to a growth in the population and an increase in chronic illnesses throughout the world. Segmentation By Product Instruments Reagents & Consumables By Technology Immunohistochemistry In-Situ Hybridization Digital Pathology & Workflow Management Others By Disease Breast Cancer Prostate Cancer Gastric Cancer Other Cancers By End-User Hospitals Research Laboratories Pharmaceutical Companies Contract Research Organizations Others Tissue Diagnostics Market Dynamics Tissue Diagnostics Market Size Supply & Demand Current Trends/Issues/Challenges Competition & Companies Involved in the Market Value Chain of the Market Market Drivers and Restraints Recent News Related to Market In 2019, Roche and GE Healthcare have agreed to collaborate on the development of an integrated digital diagnostics platform aimed at improving cancer and critical care therapy. In 2019, Hologic received CE permission for ThinPrep Genesis Processor. The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are: COVID-19 pre and post business impact analysis Detailed overview of the parent market Changing market dynamics in the industry In-depth market segmentation What is the Tissue Diagnostics Market growth? Which segment accounted for the largest Tissue Diagnostics Market share? Who are the key players in the Tissue Diagnostics Market? Historical, current and projected market size in terms of volume and value Recent industry trends and developments Competitive landscape Strategies of key players and products offered Potential and niche segments, geographical regions exhibiting promising growth A neutral perspective on market performance Must-have information for market players to sustain and enhance their market footprint Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis. Table of ContentsContents1. Executive Summary 2. Global Tissue Diagnostics Market 2.1. Product Overview 2.2. Market Definition 2.3. Segmentation 2.4. Assumptions and Acronyms 3. Research Methodology 3.1. Research Objectives 3.2. Primary Research 3.3. Secondary Research 3.4. Forecast Model 3.5. Market Size Estimation 4. Average Pricing Analysis 5. Macro-Economic Indicators 6. Market Dynamics 6.1. Growth Drivers 6.2. Restraints 6.3. Opportunity 6.4. Trends 7. Correlation & Regression Analysis 7.1. Correlation Matrix 7.2. Regression Matrix 8. Recent Development, Policies & Regulatory Landscape 9. Risk Analysis 9.1. Demand Risk Analysis 9.2. Supply Risk Analysis 10. Global Tissue Diagnostics Market Analysis 10.1. Porters Five Forces 10.1.1. Threat of New Entrants 10.1.2. Bargaining Power of Suppliers 10.1.3. Threat of Substitutes 10.1.4. Rivalry 10.2. PEST Analysis 10.2.1. Political 10.2.2. Economic 10.2.3. Social 10.2.4. Technological 11. Global Tissue Diagnostics Market 11.1. Market Size & forecast, 2020A-2030F 11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12. Global Tissue Diagnostics Market: Market Segmentation 12.1. By Regions 12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.1.2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.1.3. Asia-Pacific: (China, India, Japan, South Korea, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.2. By Product: Market Share (2020-2030F) 12.2.1. Instruments, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.2.2. Reagents and Consumables, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.3. By Technology: Market Share (2020-2030F) 12.3.1. Immunohistochemistry , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.3.2. In-Situ Hybridization, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.3.3. Digital Pathology & Workflow Management, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.3.4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4. By Diseases: Market Share (2020-2030F) 12.4.1. Breast cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4.2. Prostate cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4.3. Gastric cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.4.4. Other cancers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.5. By End-User: Market Share (2020-2030F) 12.5.1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.5.2. Pharmaceutical Companies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.5.3. Contract Research Organizations, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 12.5.4. Research Laboratories, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F 13. Company Profile 13.1. Abbott Laboratories 13.1.1. Company Overview 13.1.2. Company Total Revenue (Financials) 13.1.3. Market Potential 13.1.4. Global Presence 13.1.5. Key Performance Indicators 13.1.6. SWOT Analysis 13.1.7. Product Launch 13.2. Agilent Technologies Inc. 13.3. BioGenex Laboratories 13.4. Cancer Genetics Inc. 13.5. Danaher Corporation 13.6. Hoffmann-La Roche Ltd 13.7. Genomic Health Inc. 13.8. Merck KGaA 13.9. Thermo Fisher Scientific. 13.10. Bio Rad 13.11. Biomeriux Consultant Recommendation **The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
Fatpos Global 社の最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問Fatpos Global社はどのような調査会社ですか?Fatpos Globalは経営コンサルティング、アドバイザリー、市場調査サービスを提供し、市場調査レポートを出版しているインドに主拠点をおく調査会社です。 Fatposは“Failures A... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/08 10:26 154.13 円 166.76 円 202.76 円 |